<--- Back to Details
First PageDocument Content
Piperazines / Orphan drugs / Pyridines / Medicine / Myeloid leukemia / Chronic myelogenous leukemia / Philadelphia chromosome / Abl gene / Dasatinib / Organic chemistry / Pyrimidines / Chemistry
Piperazines
Orphan drugs
Pyridines
Medicine
Myeloid leukemia
Chronic myelogenous leukemia
Philadelphia chromosome
Abl gene
Dasatinib
Organic chemistry
Pyrimidines
Chemistry

Chronic myeloid leukaemia, chronic phase First line initial PBS authority application Supporting information When to use this form

Add to Reading List

Source URL: www.humanservices.gov.au

Download Document from Source Website

File Size: 256,00 KB

Share Document on Facebook

Similar Documents

A typical maintenance dose is 2-6 mg orally each day for 14 or buy gleevec online uk 21 days. These opinions do not need them. Do not take this medication guide. These opinions do not change the way that is actually good

A typical maintenance dose is 2-6 mg orally each day for 14 or buy gleevec online uk 21 days. These opinions do not need them. Do not take this medication guide. These opinions do not change the way that is actually good

DocID: 1qGzY - View Document

Postgraduate Projects  Centre for Cancer Biology Building a new generation of world-leading cancer researchers

Postgraduate Projects Centre for Cancer Biology Building a new generation of world-leading cancer researchers

DocID: 1qbt6 - View Document

05-AUG:10 LEUK ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

05-AUG:10 LEUK ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

DocID: 1p0FU - View Document

From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

DocID: 1nEJu - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1nCHs - View Document